Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation Modulates the Response of Zoledronic-Acid-Treated Osteoblast-like SaOs-2 Cells: Implications for Bisphosphonate-Related Osteonecrosis

In conclusion, PBM modulated the response of SaOs-2 osteoblastic cells treated with ZA in a wavelength- and dose-dependent manner.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied SaOs-2 osteoblast-like cells treated with zoledronic acid, a bisphosphonate, to mimic bisphosphonate-related osteonecrosis of the jaw, then exposed them to laser photobiomodulation at 660 nm and 808 nm. They report that the 808 nm, 1 J treatment attenuated the drop in metabolic activity and increased BCL-2 expression, but did not reverse apoptosis. The study was performed in vitro, so the findings may not apply to living patients.

Who or what was studied
SaOs-2 osteosarcoma cells (in vitro cell culture) treated with zoledronic acid
Wavelengths
660, 808 nm
Limits stated in the abstract
The study was performed only in vitro on cultured cells, and photobiomodulation did not reverse zoledronic acid-induced apoptosis.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

This study aimed to evaluate the effects of laser photobiomodulation (PBM) therapy in SaOs-2 osteosarcoma cells treated with zoledronic acid (ZA), a bisphosphonate, in vitro, mimicking a bisphosphonate-related osteonecrosis of the jaw (BRONJ) situation. Cells were treated with 100 μM ZA for 24 h and subjected to PBM using wavelengths of 660 nm and 808 nm at energy delivered of 1, 5, 10, and 20 J. After 24 h, metabolic activity, apoptosis, and BAX and BCL-2 gene expression were analyzed. Data were compared using one-way ANOVA followed by Tukey's post hoc test (p < 0.05). ZA significantly reduced metabolic activity (p < 0.05), an effect attenuated by PBM at 808 nm with 1 J, while BCL-2 expression increased with 1 J at 660 nm and with 1 J and 20 J at 808 nm. However, PBM did not reverse ZA-induced apoptosis. In conclusion, PBM modulated the response of SaOs-2 osteoblastic cells treated with ZA in a wavelength- and dose-dependent manner. PBM at 808 nm and 1 J stimulated cell metabolic activity and upregulated BCL-2 expression, suggesting a potential protective effect against ZA-induced cytotoxicity.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
660 nm, 808 nm
Total energy
20 J, 1 J

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Wavelength, Laser, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies